Abstract: Human body composition is important in numerous cancer research domains. Our objective was to evaluate clinically accessible methods to achieve practical and precise measures of body composition in cancer patients. Dualenergy X-ray absorptiometry (DXA)-based analysis of fat and fat-free mass was performed in 50 cancer patients and compared with bioelectrical impedance analysis (BIA) and with regional computed tomography (CT) images available in the patients' medical records. BIA overestimated or underestimated fat-free mass substantially compared with DXA as the method of reference (up to 9.3 kg difference). Significant changes in fat-free mass over time detected with DXA in a subset of 21 patients (+2.2 ± 3.2%/100 days, p = 0.003), was beyond the limits of detection of BIA. Regional analysis of fat and fat-free tissue at the 3rd lumbar vertebra with either DXA or CT strongly predicted whole-body fat and fat-free mass (r = 0.86-0.94; p < 0.001). CT images provided detail on specific muscles, adipose tissues and organs, not provided by DXA or BIA. CT presents great practical significance due to the prevalence of these images in patient diagnosis and follow-up, thus marrying clinical accessibility with high precision to quantify specific tissues and to predict whole-body composition.
Introduction
Body composition, specifically proportions of adipose and lean tissue, has many clinical implications in cancer patients. Increased prevalence or recurrence of breast, prostate, colorectal, and specific gastro-esophageal cancers is associated with obesity (Demark-Wahnefried et al. 2002; Kubo and Corley 2006; Otake et al. 2005; von Hafe et al. 2004 ).
Involuntary weight loss, involving muscle and fat loss, frequently accompanies advanced disease and is associated with poor response to treatment and shortened survival (Dewys et al. 1980; Vigano et al. 2000) . Also, fat and lean tissue compartments represent sites for distribution of lipidand water-soluble drugs, respectively, and are likely determinants of chemotherapy efficacy and toxicity (Aslani et al. 2000; Prado et al. 2007) .
Methods for evaluating human body composition have been developed and validated for research focused on aging and chronic diseases (e.g., obesity, chronic obstructive pulmonary disease) (Baumgartner et al. 1998; Cosqueric et al. 2006; Ross et al. 2000; Steiner et al. 2002; Kyle et al. 2004a Kyle et al. , 2004b . Through this research, distinct tissues have been associated with specific health outcomes. For example, insulin resistance is associated with visceral adipose tissue accumulation (Otake et al. 2005; Ross et al. 2000) and loss of skeletal muscle is associated with physical disability (Baumgartner et al. 1998) and disease outcomes such as nosocomial infections (Cosqueric et al. 2006 ).
Dual energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and computed tomography (CT) are generally regarded as gold standard methods in the evaluation of human body composition. Bioelectrical impedance analysis (BIA) is an inexpensive, expedient, and accessible method that has been commonly used to measure body composition in clinical populations (Kyle et al. 2004a (Kyle et al. , 2004b . Although BIA is safe and inexpensive and does not expose patients to radiation, it may not have the specificity and precision of DXA, MRI, and CT. DXA is not usually available in cancer settings; however, CT imaging is a clinically accessible alternative. Here, we evaluated regional CT images acquired during routine patient care, as a potential resource to discriminate and to quantify important and distinct features of the body composition of patients with advanced cancer. CT image analysis at defined skeletal landmarks has already been established as a precise means of following gain or loss of tissue over time (Ross et al. 2000) . Single images at key lumbar vertebral landmarks are known to be good correlates of whole-body fat and lean tissue mass in healthy populations (Shen et al. 2004a (Shen et al. , 2004b . A secondary aim of this study was to compare estimates of whole-body composition obtained by BIA and CT, with those obtained by DXA.
Materials and methods

Subjects and study design
Fifty-one patients (n = 51) with locally advanced or metastatic non-small cell lung or colorectal cancer provided written consent to participate; *96% of these patients were Caucasian. Demographic features of the sample were compared with those of a population cohort of patients presenting with the same diseases (n = 1806) at our regional cancer centre. The study was approved by the Research Ethics Board of the Alberta Cancer Board.
One patient exceeded the weight limit of the DXA scanner and 3 patients were excluded from BIA analysis owing to calused feet, which impeded proper conductivity. Twenty-one participants returned for a second DXA and BIA evaluation after *8 weeks. Initial DXA and BIA measurements were scheduled to coincide with CT imaging for disease diagnosis or treatment follow-up. Patients were not requested to have a CT scan solely for body composition analysis; rather, CT images were acquired for the purposes of routine medical care. It should be noted that CT imaging in clinical oncology is used to detect tumors in specific anatomical sites mostly in the abdomen or thorax, and wholebody imaging is not done. Thirty-one patients (11 with nonsmall cell lung cancer; 20 with colorectal cancer) had concurrent CT images including the lumbar area.
Body composition methodology
DXA precisely depicts whole-body fat mass (FM) and fatfree mass (FFM), has the capacity for regional analysis, and is widely used to assess skeletal muscle based on analysis of the limbs (Baumgartner et al. 1998; Heymsfield et al. 1990 ). MRI and CT allow the precise segregation of individual tissues (Fig. 1) . Tissue areas in single MRI/CT images at specific lumbar landmarks relate significantly to whole-body muscle in healthy adults and these relationships are linear over a very wide range (Shen et al. 2004a (Shen et al. , 2004b ; for this reason scans including the lumbar region were considered. BIA is a convenient and cost-effective, but indirect, measure that is based on disparate electrical conductivity of fat and lean tissue. We also used a common anthropometric descriptor: body mass index (BMI (kg/m 2 ) = body mass/height 2 ).
Patients were instructed to refrain from consuming alcohol for 24 h, food for 8-12 h, and fluids for 2 h prior to DXA and BIA. Height and mass were measured with subjects barefoot and in a hospital gown, followed immediately by BIA and DXA assessments. Principles and methods of DXA analysis can be found elsewhere (Heymsfield et al. 1997 ). We used a General Electric Lunar Prodigy High Speed Digital Fan Beam X-Ray-Based Densitometer and en-CORE 9.20 software for analysis. Our coefficient of variation was 2.0% for fat mass and 0.8% for lean mass using this instrument. DXA scans were partitioned at the acromiohumeral and pelvic-femoral joints (Fig. 1) where tissues located distally from these partitions were characterized as appendicular tissues and the medial tissues were characterized as trunk (Fig. 1) . Appendicular FFM represents skeletal muscle in DXA analysis (Baumgartner et al. 1998; Heymsfield et al. 1990) . Regional analysis at the 3rd lumbar vertebra (L3) was conducted (Fig. 1) , and the identical field of view was used for the CT image analysis. Since the height of L3 varied among patients (3.79 ± 0.41 cm), tissue mass from DXA regional analysis was standardized to a 1-cm-thick slice equivalent; CT images were analyzed as cross-sectional areas and thus the height of L3 was irrelevant.
Details of the use of CT image analysis to determine body composition can be found elsewhere (Heymsfield et al. 1997) . Images were analyzed for tissue cross-sectional area (cm 2 ) using Slice-O-Matic software V4.3 (Tomovision, Montreal, Quebec, Canada). CT Hounsfield unit thresholds were -29 to 150 for skeletal muscle (Heymsfield et al. 1990) , -190 to -30 for subcutaneous and intra-muscular adipose tissue (Heymsfield et al. 1990) , and -50 to -150 for visceral adipose tissue (Miller et al. 1998) . Tissue boundaries were manually corrected as necessary. Two consecutive images extending from the 3rd lumbar vertebrae in the infe-rior direction were assessed for adipose tissue (visceral, subcutaneous, and intramuscular), total lean tissue, and total muscle (psoas, erector spinae, quadratus lumborum, transversus abdominus, external and internal obliques, and rectus abdominus). Total fat-free tissue analysis at L3 comprised bone and soft tissues excluding intestinal contents. The coefficient of variability for the skeletal muscle measurements was 1.6% and for adipose tissue measurements it was 2.3%. Spleen and liver volumes were computed by multiplying the cross-sectional area of each consecutive image by the distance between each image (5 mm). The coefficient of variability for spleen volume was 2.8% and for liver volume it was 2.6%.
A single frequency electrical signal (50 kHz, 500 mA) was used for foot-to-foot BIA analysis (Tanita Body Composition Analyzer TBF-300A). Foot-to-foot analysis has been previously shown to generate similar resistance measures at 50 kHz to hand-to-foot BIA (Cox-Reijven et al. 2002; Ritchie et al. 2005) . Our BIA instrument generated resistance values that were used along with patient height, age, and sex to calculate FFM from predictive equations in the literature. We included 2 formulas from the European Society of Clinical Nutrition and Metabolism guidelines (Kyle et al. 2004a (Kyle et al. , 2004b ) that were derived from large populations: one from Deurenberg et al. (1990) for the elderly and one from Steiner et al. (2002) for chronic obstructive pulmonary disease. FFM estimates also included those derived in cancer patients (Simons et al. 1995; Isenring et al. 2004 ), normalweight adults (Segal et al. 1988) , pulmonary disease (Kyle et al. 1998) , and obesity (Gray et al. 1989 ) as our study patients generally presented one or more of these features. FFM derived from each of these equations was compared to DXA. Isenring et al. (2004) performed foot-to-foot BIA analysis with these equations.
Units of measurement and expression
Fat and fat-free tissues, evaluated with DXA, are expressed conventionally in kilograms. CT data are presented in the units of the primary measure, cross-sectional areas (cm 2 ). When specific fat-free tissues (i.e., skeletal muscle) measured with CT were compared with FFM measured with DXA, bone mineral content was excluded (i.e., Figs. 5 and 6); for all other fat-free tissue comparisons, bone mineral content was included (i.e., Figs. 2, 3B, 4B, 4D; Tables 2, 3) .
For the purpose of comparing to literature values (Baumgartner et al. 1998) , measurements for appendicular skeletal muscle using DXA and muscle measured by CT ( Fig. 6 ) were normalized to each patient's height 2 . Since the timing of CT scans was dictated by clinical factors and was different for each patient, loss or gain of tissue over time was expressed as a percentage and was divided by the number of days between scans. This value was then multiplied by 100 days to provide a standardized unit, % change/100 days, for more accurate comparisons between patients. The same approach was used for calculating changes in tissue measured by DXA and BIA (Table 2) .
Statistics
Data are presented as means ± SD. Statistical significance was accepted at p < 0.05. Student's t test and the 2 test were used as indicated in the results section. Pearson correlations were used to compare body compositions determined by DXA, CT, and BIA, and included both sexes because age and sex do not impact these relationships (Shen et al. 2004b) . For the relationships that would be used for extrapolating regional tissue to corresponding whole-body mass, we have included the standard error of estimate (SEE) to provide the accuracy of the regression model relative to the population studied. The mean absolute residual error (MRE) is also presented to indicate the error associated with individual data relative to the predictive equation. A Bland and Altman plot (Bland and Altman 1986 ) was used to evaluate the sensitivity of the equation for predicting FFM using BIA relative to DXA-based measurements.
Results
Characteristics of the study participants were highly comparable with those of the overall population cohort presenting with similar diseases and stages (Table 1) . Over 50% of both populations were overweight or obese and a small proportion (4%-6%) were underweight. The patients BMI ranged from 17.7 to 35.9 kg/m 2 . These patients were within the range considered acceptable for BIA analysis (Kyle et al. 2004a (Kyle et al. , 2004b ) as well as DXA. 
BIA
Compared with other prediction equations tested, that of Kyle et al. (1998) gave the best estimate of FFM compared with the reference method, DXA. The deviation between estimated FFM from BIA using the predictive equation of Kyle et al. (1998) is depicted in a Bland and Altman (1986) plot (Fig. 2) , demonstrating that BIA estimates of FFM were often substantially discrepant from DXA determinations, which range from -9.3 to +7.3 kg. This discrepancy was not systematic: BIA largely underestimated FFM in patients with higher FFM and overestimated in patients with lower FFM. Since BIA generated poor FFM estimates, which were required for estimating fat mass or appendicular muscle mass, these were not computed. BIA also lacked the capacity to detect overall changes in FFM compared with DXA. For the patients in Table 2 , a mean gain of FFM of 2.2 ± 3.2%/100 days (p < 0.05) was detected by DXA. However, a parallel analysis of the same patients by BIA rendered a mean rate of change of -1.0 ± 6.8%/100 days which compared poorly to DXA and had a large standard deviation.
Regional and whole-body composition: DXA vs. CT analysis
On a whole-body basis, study patients were on average 34.0% ± 9.4% (9.9 ± 3.8 kg/m 2 ) fat and 63.2% ± 8.9% (16.5 ± 2.6 kg/m 2 ) fat-free tissue (excluding bone mineral content) by DXA analysis. Fat and muscle tissue measurements using CT analysis at L3 are shown in Table 3 . The range of lumbar total muscle cross-sectional areas are comparable to those we recently observed in a cohort of 250 cancer patients (155.1 ± 38.6 cm 2 ; range 79.2-271.5 cm 2 , Prado et al. 2008) . To determine whether L3 was representative of the whole body, a series of comparisons were conducted (Figs. 3-5) . The L3 FM and FFM to whole-body relationships were evaluated with DXA (Figs. 3A and 3B, respectively):
whole-body FM (kg) = 34.61 Â [FM at L3 (kg/1 cm slice)] -2.17; r = 0.82; p < 0.001 whole-body FFM (kg) = 101.9 Â [FFM at L3 (kg/1 cm slice)] + 9.023; r = 0.89; p < 0.001
The relationships between DXA and CT-based measurements were also resolved for fat and fat-free tissue. CT and DXA were directly compared at L3 ( The regressions presented here ranged from r = 0.83 to 0.97 for FM and FFM and were highly comparable to correlations of single-image to whole-body fat (r = 0.842-0.963) and muscle (r = 0.712-0.924) previously demonstrated using MRI in a healthy population (Shen et al. 2004a) .
Skeletal muscle
CT analysis of skeletal muscle at L3 strongly related to whole-body FFM and to appendicular skeletal muscle mass as measured by DXA, respectively: whole-body FFM (kg) = 0.30 Â [skeletal muscle at L3 using CT (cm 2 )] + 6.06; r = 0.94; p < 0.001; SEE = 0.72 kg; MRE = 2.94 ± 2.46 kg (Fig. 5) Appendicular skeletal muscle / height 2 (kg/m 2 ) = 0.11 Â [skeletal muscle at L3 using CT / height 2 (cm 2 /m 2 )] + 1.17; r = 0.89; p < 0.001; SEE = 0.10 kg/m 2 ; MRE = 0.45 ± 0.33 kg/m 2 (Fig. 6) The latter two relationships are potentially useful for relating CT-based measures with those made with other methods. For example, sex-specific cutoffs for low appendicular muscle mass have been defined using DXA analysis (males, <7.26 kg/m 2 ; females, <5.45 kg/m 2 ). These cutoffs for low muscle mass associate with physical disability, falls, and mortality in elderly adults. The equation derived from the analysis in Fig. 6 suggests that corresponding cutoffs for lumbar skeletal muscle index are *<55.4 cm 2 /m 2 for males and <38.9 cm 2 /m 2 in females. The incidence of low muscle mass was considerable; 28 of 50 patients showed this feature.
Specific tissue analysis: DXA and CT
Whereas FFM in limbs is skeletal muscle, FFM in the trunk is a composite of muscle, liver, spleen, tumor, and other organs (Heymsfield and McManus 1985) . Trunk FFM represented 58.1% ± 3.7% of whole-body FFM. The liver volume, which in some patients included hepatic metastases, was 1.7 ± 0.5 L (range 0.7-3.0 L). Spleen volume ranged 5-fold (from 110 to 680 mL). Because the trunk represented a large fraction of whole-body FFM, change in whole-body FFM was related to changes in trunk FFM (r = 0.88, p < 0.05, Table 2 ). In contrast appendicular skeletal muscle mass related less well with the rate of change in whole-body FFM (r = 0.49, p < 0.05, Table 2 ).
Specific tissue analysis: abdominal region
The power of CT imaging to discriminate specific tissue changes (skeletal muscle, liver, spleen, total adipose tissue) is illustrated in a series of CT images in a colorectal cancer patient (Table 4) . A progressive loss of *7.0 kg of adipose tissue was evident following an earlier period of fat gain of *1.7 kg. Loss of skeletal muscle of *3.0 kg occurred during the final 5 months of life while simultaneous late-stage hepatomegaly and extensive hepatic metastases were evident (*+2.4 L in the final 70 days of life). This concurrent loss of muscle and gain in liver mass clearly indicates that important tissue-specific changes could occur that would not be detected by either DXA or BIA.
Discussion
CT imaging as a method of choice for clinical measure of body composition in oncology patients
We propose that CT image analysis is a clinically practical and precise method of evaluating the unique features of body composition in patients with cancer. The potential applicability of this approach is very broad, since imaging is a key basis of diagnosis and follow-up. More than 90% of patients with advanced cancers at our centre have CT images that could be evaluated in the manner described here. CT/MRI and DXA stand as ''gold standards'' in human body composition analysis, however, CT/MRI images have greater availability in cancer centres compared with DXA. CT images encompassing selected regions of the body are frequently taken as part of standard care and could be interpreted to provide information on body composition without incremental cost or radiation exposure. CT and MRI are the only modalities that can be used to precisely quantify specific fat depots, muscles and organs. These attributes of CT imaging analysis place this tool in the forefront as a principal instrument for clinical measures and research.
Predictive value of regional analysis for whole-body composition
Tissue areas in single MRI/CT images at lumbar landmarks relate significantly to whole-body muscle (r 2 = 0.855) and fat (r 2 = 0.927) in healthy adults and these relationships are linear over a very wide range of total fat mass (10-60 kg) and muscle mass (10-60 kg) (Shen et al. 2004a) . Our work provides evidence that the linearity of relationships between L3 and whole-body fat and fat-free compartments are maintained in cancer patients. These relationships are potentially useful for relating CT-based assessments with measures made with other methods. For example, the relationship illustrated in Figs. 5 and 6 allows CT-based evaluations to be related to measures of whole-body fat-free mass and appendicular skeletal muscle that are often found in the literature. Finally, within the limits of its error terms, regional CT imaging is a practical surrogate for whole-body imaging. CT can be used with reasonable precision to predict whole-body measures for individual patients, these relationships provide a highly precise method (with standard error of our regression models of less than 1.2 kg) for predicting corresponding whole-body measures in groups of patients.
A need to discriminate behaviour of distinct elements of the lean body mass
Whole-body lean mass cannot be interpreted as a single entity. The trunk and appendices clearly show disparate behaviours. Although FFM in the limbs (skeletal muscle) did not change over time, trunk FFM increased progressively and had a strong influence on whole-body FFM. This dispa- rate behaviour between the trunk and limbs of cancer patients was also reported by Fouladiun et al. (2005) , who showed that advanced cancer patients lost appendicular skeletal muscle mass while gaining FFM in the trunk. The trunk is a heterogeneous composite of lean tissues including skeletal muscle, liver, spleen, tumor, as well as intestines and their contents, and each tissue may exhibit distinct changes during disease progression (Fouladiun et al. 2005; Heymsfield and McManus 1985) .
A gain or loss of whole-body FFM is often used as a clinical outcome in evaluating anorexia-cachexia therapy based on the assumption that a gain in FFM is beneficial (i.e., composed of functional skeletal muscle). Here we demonstrated that a gain in FFM may actually indicate disease progression (e.g., the 2.4 L increase in metastatic disease in the liver of the example patient). A tissue-specific approach to following lean tissue changes would thus seem highly relevant.
The presence of ascites and alterations in hydration status, two factors that are frequently present in advanced cancer patients are already known to confound the results of BIA analysis (Kyle et al. 2004b; Sarhill et al. 2000) . Furthermore, BIA identifies whole-body FFM as a single entity, and makes no account of the proportions of different lean tissues. We showed that the strongest correlations for BIA estimates of FFM were generated by the equation of Kyle et al. (1998) , which were substantially discrepant with DXA by up to *9 kg. However, it is important to consider that the regression from Kyle et al. (1998) was derived using a DXA Hologic scanner as opposed to the Lunar Prodigy scanner that was used in the present study. As discussed in Genton et al. (2006) , the difference in equipment may contribute, in part, to the discrepancy between BIA and DXA FFM values. However, equation from Kyle et al. (1998) showed the best correlation between BIA and DXA, and these inconsistencies between DXA and BIA are in accordance with data from Simons et al. (1995) . BIA has been an outcome measure in randomized clinical trials of anorexiacachexia therapy (Shang et al. 2006 ); however, we have shown that BIA also lacks precision in detecting changes in FFM over time. Sample-size calculations based on the standard deviations in our data suggest that detecting a 5% change in FFM would require almost 4 times more patients if using BIA rather than DXA.
Specific methods for applications in clinical oncology
Regional CT images are ubiquitously available for cancer patients as they are normally performed for staging as well as assessing treatment success or disease progression. Whole-body CT scans are rarely taken. The field is limited to the expected sites or tumor in a specific anatomical region of the body (e.g., abdominal region which usually includes the most inferior thoracic vertebrae (T10-T12) and the superior lumbar vertebrae (L1-L4)). These fields normally encompass organs such as liver and spleen, for which volumes can be determined. Usual diagnostic scans do not encompass the entire volume of any specific muscle groups or adipose tissues, so the available information on these is limited to cross-sectional areas. Measurements of tissue areas are exceedingly precise for looking at longitudinal change within an individual and very powerful for detecting the rate of loss or gain. Additionally, cross-sectionals area can be extrapolated to whole-body measures.
Body composition of cancer patients may be followed for different purposes. For example, prevalence of colorectal cancer may be specifically associated with increased visceral adipose tissue (Otake et al. 2005) . CT/MRI image analysis is the only approach that permits the explicit evaluation of visceral adipose tissue; DXA cannot discriminate visceral adipose tissue. BIA is not only incapable of discriminating between different depots of adipose tissue, but total fat mass is calculated as body weight minus estimated fat-free mass, which in turn showed important discrepancy with DXA. Body composition change during involuntary weight loss is complex and involves concurrent changes in many tissues, all of which can be followed with high precision using CT/MRI analysis. DXA is also useful in this application, provided the limbs (representing muscle) and trunk are considered separately. The disparate proportions and behaviour of the different tissues within the trunk compartment can only be appreciated with CT/MRI. a Appendicular skeletal muscle and total body adipose tissue were estimated from tissue cross sectional area at L3, using the regression equations in Figs. 5 and 3C, respectively. Liver and spleen volumes were calculated using Sliceomatic software as described under Materials and methods.
In clinical pharmacology, proportions of fat and lean tissue in the body may represent sites for the distribution of lipid-and water-soluble drugs, respectively. Whole-body DXA is appropriate for this determination; however, the regressions presented here can be used to extrapolate singleslice values from CT analysis to corresponding whole-body values. In related work (Prado et al. 2007 (Prado et al. , 2008 , we used these relationships to predict whole-body FFM of colorectal cancer patients, specifically the relationship between muscle area at L3 with whole-body FFM ( Fig. 5 ; r = 0.94). We were then able to estimate the variation in 5-fluorouracil doses per unit of FFM between patients and to relate this variation to 5-fluorouracil toxicity. Finally, where there might be interest in the hepatic mass in relation to the metabolism of drugs, analysis of in CT/MRI images provides a precise means of quantifying liver volume.
Body composition features of patients with advanced cancer
Our study participants were representative of a larger population of patients seen at our centre. Study participants had a wide range of BMIs, with an average of 34% body fat, which is consistent with the definition of obesity (Baumgartner 2000) . More than 50% of our patients were below the cutoffs for sarcopenia (low skeletal muscle mass) described by Baumgartner et al. (1998) . The concurrent presence of obesity and low muscle mass represent a population profile tending toward a body phenotype referred to as sarcopenic obesity. Sarcopenic obesity is associated with increased health risks compared with patients who are either obese or sarcopenic (Baumgartner 2000; DemarkWahnefried et al. 2002) . These risks include longer hospital stays, increased infectious and non-infectious complications, and increased mortality in hospital (Cosqueric et al. 2006; Bochicchio et al. 2006 ). Sarcopenic obesity is associated with poor functional status and mortality in cancer patients (Prado et al. 2008) .
Conclusion
CT imaging, with its excellent resolution of adipose tissue and skeletal muscles, provides a capacity to test the implications of these distinct attributes in cancer patients. Regional analysis of fat and lean tissue are highly correlated to corresponding whole-body compartments and can provide precise quantification of specific adipose tissues, skeletal muscles, and organs. While DXA also provides high precision, it is not readily available in cancer centres. In contrast, BIA is clinically available, but provides highly discrepant results when compared with gold standard methodologies.
